Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics

Post‐transplant diabetes mellitus (PTDM) shows a relationship with risk factors including obesity and tacrolimus‐based immunosuppression, which decreases pancreatic insulin secretion. Several of the sodium–glucose‐linked transporter 2 inhibitors (SGLT2is) and glucagon‐like peptide 1 receptor agonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Hecking, Manfred, Sharif, Adnan, Eller, Kathrin, Jenssen, Trond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839745/
https://www.ncbi.nlm.nih.gov/pubmed/33135259
http://dx.doi.org/10.1111/tri.13783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839745/
https://www.ncbi.nlm.nih.gov/pubmed/33135259
http://dx.doi.org/10.1111/tri.13783

Ejemplares similares